NO20034561D0 - Anvendelse av kationiske dekstranderivater for beskyttelse av dosebegrensende organer - Google Patents

Anvendelse av kationiske dekstranderivater for beskyttelse av dosebegrensende organer

Info

Publication number
NO20034561D0
NO20034561D0 NO20034561A NO20034561A NO20034561D0 NO 20034561 D0 NO20034561 D0 NO 20034561D0 NO 20034561 A NO20034561 A NO 20034561A NO 20034561 A NO20034561 A NO 20034561A NO 20034561 D0 NO20034561 D0 NO 20034561D0
Authority
NO
Norway
Prior art keywords
protection
dose limiting
dextran derivatives
cationic dextran
limiting organs
Prior art date
Application number
NO20034561A
Other languages
English (en)
Other versions
NO20034561L (no
Inventor
Anders Holmberg
Jukka Olavi Hiltunen
Giovanni Paganelli
Marta Cremonesi
Original Assignee
Map Medical Technologies Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Map Medical Technologies Oy filed Critical Map Medical Technologies Oy
Publication of NO20034561D0 publication Critical patent/NO20034561D0/no
Publication of NO20034561L publication Critical patent/NO20034561L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20034561A 2001-04-11 2003-10-10 Anvendelse av kationiske dekstranderivater for beskyttelse av dosebegrensende organer NO20034561L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20010764A FI20010764A0 (fi) 2001-04-11 2001-04-11 Kationiset dekstraanijohdannaiset käytettäväksi munuaisten suojaamiseen
PCT/FI2002/000305 WO2002083154A1 (en) 2001-04-11 2002-04-11 Use of cationic dextran derivatives for protecting dose-limiting organs

Publications (2)

Publication Number Publication Date
NO20034561D0 true NO20034561D0 (no) 2003-10-10
NO20034561L NO20034561L (no) 2003-12-09

Family

ID=8560975

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034561A NO20034561L (no) 2001-04-11 2003-10-10 Anvendelse av kationiske dekstranderivater for beskyttelse av dosebegrensende organer

Country Status (13)

Country Link
EP (1) EP1383517A1 (no)
JP (1) JP2004525181A (no)
KR (1) KR20040018350A (no)
BR (1) BR0208860A (no)
CA (1) CA2443052A1 (no)
EE (1) EE200300502A (no)
FI (1) FI20010764A0 (no)
HU (1) HUP0401386A3 (no)
IL (1) IL158153A0 (no)
NO (1) NO20034561L (no)
PL (1) PL363024A1 (no)
RU (1) RU2003132683A (no)
WO (1) WO2002083154A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8685458B2 (en) 2009-03-05 2014-04-01 Bend Research, Inc. Pharmaceutical compositions of dextran polymer derivatives
EP2411137B1 (en) 2009-03-27 2016-09-07 Bend Research, Inc. Spray-drying process
US8815294B2 (en) 2010-09-03 2014-08-26 Bend Research, Inc. Pharmaceutical compositions of dextran polymer derivatives and a carrier material
WO2012031133A2 (en) 2010-09-03 2012-03-08 Bench Research, Inc. Spray-drying apparatus and methods of using the same
EP2611529B1 (en) 2010-09-03 2019-01-23 Bend Research, Inc. Spray-drying method
WO2012040502A1 (en) 2010-09-24 2012-03-29 Bend Research, Inc. High-temperature spray drying process and apparatus
US9060938B2 (en) 2011-05-10 2015-06-23 Bend Research, Inc. Pharmaceutical compositions of active agents and cationic dextran polymer derivatives
DE102014016901B4 (de) * 2014-09-17 2021-08-12 Friedrich-Schiller-Universität Jena Verfahren zur Herstellung für neue Dextranderivate als Wirkstoffträgersystem und deren Verwendung
US20190353565A1 (en) * 2016-12-01 2019-11-21 Norbert Gretz Means and methods for visualization of tissue structures
US20230104323A1 (en) * 2019-12-14 2023-04-06 Manu Chaudhary Formulations of polybasic drugs to reduce multi-organ toxicity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3414491A1 (de) * 1984-04-17 1985-10-24 Hans Dr. 8202 Bad Aibling Dietl L-aminosaeurengemische fuer die parenterale und orale anwendung bei nierenerkrankungen
US5290538A (en) * 1988-12-22 1994-03-01 Skrezek Christian Nephro protective infusion solutions
SE9803482D0 (sv) * 1998-10-13 1998-10-13 Anders Holmberg Ion exchange tumor targeting (IETT)
AU6275800A (en) * 1999-07-16 2001-02-05 Mallinckrodt, Inc. Inhibition of renal uptake of molecules that are potentially damaging for the kidney

Also Published As

Publication number Publication date
RU2003132683A (ru) 2005-04-10
CA2443052A1 (en) 2002-10-24
HUP0401386A2 (hu) 2004-12-28
IL158153A0 (en) 2004-03-28
EE200300502A (et) 2003-12-15
WO2002083154A1 (en) 2002-10-24
BR0208860A (pt) 2004-10-19
EP1383517A1 (en) 2004-01-28
HUP0401386A3 (en) 2005-06-28
KR20040018350A (ko) 2004-03-03
JP2004525181A (ja) 2004-08-19
NO20034561L (no) 2003-12-09
FI20010764A0 (fi) 2001-04-11
PL363024A1 (en) 2004-11-15

Similar Documents

Publication Publication Date Title
CY2019030I2 (el) Παραγωγο ραπαμυκινης για την θεραπευτικη αντιμετωπιση του καρκινου του πνευμονα
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
NO20025792L (no) Kinazolinderivater for behandling av tumorer
NO20013380D0 (no) 2-aminobenzoksazinonderivater for behandling av fedme
NO20033594D0 (no) Fenetanolamin-derivater for behandling av luftveissykdommer
ATE261933T1 (de) Admantan derivate
NO20013381D0 (no) 2-oksybenzoksazinonderivater for behandling av fedme
NO20014379L (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
NO20021400D0 (no) Terapeutiske konazolinderivater
CY2014019I1 (el) Παραγωγα φαιναιθανολαμινης για θεραπεια ασθενειων του αναπνευστικου
NO20042140L (no) Terapeutiske quionolonforbindelser med 5-HT anatagonistiske egenskaper
NO20034780D0 (no) Antiangiogenisk kombinasjonsterapi for behandling av kreft
NO20042635L (no) 5-Sulfanyl-ñH-1,2,4-triazol-derivater og deres anvendelse som medisin
ATE273962T1 (de) 5-phenyl-pyrimidine derivate
NO20031615D0 (no) Pyrazol-derivater for behandling av virus-sykdommer
NO20040516L (no) Kombinasjonsterapi for behandling av kreft.
IS6917A (is) Epóþílon afleiður til meðhöndlunar erfiðra æxla
NO20034561D0 (no) Anvendelse av kationiske dekstranderivater for beskyttelse av dosebegrensende organer
ATE317389T1 (de) 4-phenyl-pyrimidine derivate
NO20042640L (no) Fremgangsmate for fremstilling av ekinocandinderivater
NO20020784D0 (no) Medikament for behandling av brudd
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
EE200300466A (et) Püridoindolooni derivaatide kasutamine ravimite valmistamiseks
NO20041320L (no) Anvendelse av spesifikk dose av fondaparinux-natrium for behandling av ACS
NO20014026L (no) Krampestillende derivater til behandling av betydelig skjelving

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application